Definitive Contract HHSF223201710029C
Award Date 5/4/17
Potential Completion Date 6/30/22
Potential Value $140K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Available for Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Honolulu, HI 96813, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $501,949.66 firm fixed price contract awarded by the Food and Drug Administration (FDA) to the Rhode Island Department of Health to conduct inspections of mammography facilities in Rhode Island under the Mammography Quality Standards Act (MQSA). The contract has an ultimate completion date of January 14, 2028. The Rhode Island Department of Health, a U.S. state government entity, will be the prime contractor delivering these inspection services. This contract award is not associated...
- The Food and Drug Administration awarded a firm fixed price definitive contract valued at one million one hundred thirty thousand fifteen dollars and eighty-one cents ($1,130,015.81) to the Florida Department of Health for MQSA inspections. The place of performance is Tallahassee, Florida. No set-aside designation was used for this contract. As the designated state health agency for Florida, the Department of Health will utilize its resources across the state to conduct Mammography Quality...
- <p>This is a Definitive Contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to the Alaska Division Public Health for the ALASKA MQSA STATE INSPECTIONS requirement. The contract has a Firm Fixed Price pricing type and a total ceiling value of $362,232.76. The period of performance runs from the award date of August 17, 2023 through September 4, 2028. The contract was not set aside for any specific business type. The place of performance is Anchorage, AK.</p>
- This is a $156,785.01 firm-fixed-price definitive contract between the Food and Drug Administration (FDA) and the Puerto Rico Department of Health (PRDOH) for mammography quality standards inspections (MQSA). The contract runs from July 14, 2017 to July 13, 2022, with no set-aside designation. PRDOH, the primary government agency responsible for public health in Puerto Rico, is the prime contractor for this contract. This award is not associated with a larger contract vehicle. The contract...
- The Department of Health and Human Services Food and Drug Administration awarded a $273,313.94 firm fixed price contract to the Rhode Island Department of Health to conduct inspections of mammography facilities in the state of Rhode Island. This contract, which does not have a set-aside designation, runs from September 15, 2017 through June 30, 2022. The Rhode Island Department of Health is a state government entity that provides public health services, including managing programs related to...
- This $1,177,784.02 firm fixed-price federal contract was awarded by the Food and Drug Administration (FDA) to the Washington State Department of Health to conduct inspections of certified non-federal mammography facilities and ensure compliance with quality standards under the Mammography Quality Standards Act (MQSA). The contract has an ultimate completion date of July 21, 2027. This sole source contract was awarded without a set-aside. The Washington State Department of Health, as a state...
- The U.S. Food and Drug Administration awarded a firm fixed-price purchase order valued at $30,321.90 to the Washington State Department of Health for Mammography Quality Standards Act (MQSA) inspections. The contract was awarded on March 29, 2004, with an ultimate completion date of April 1, 2005, and performed in Tumwater, Washington. No set-aside designation was used for this procurement. The Washington State Department of Health, a state government agency specializing in public health...
- The Department of Health and Human Services Food and Drug Administration awarded a $869,858.85 definitive contract to the Hawaii Department of Health's Alcohol and Drug Abuse Division to conduct undercover inspections of tobacco retailers in Hawaii. The contract, which has no set-aside designation, requires the Alcohol and Drug Abuse Division to recruit and train youth inspectors to test retailer compliance with FDA regulations on the sale and advertising of tobacco products. The contract runs...
- This $15,636 firm-fixed price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to the Hawaii Department of Health's Children With Special Health Needs - NBS Division, a state government entity. The contract, titled "HAWAII NDI 2023", has a completion date of May 1, 2024 and is not set aside. The Hawaii Department of Health provides a range of public health services and programs, including newborn screening, disease control, and healthcare for...
- This is a definitive contract awarded by the Department of Health and Human Services Food and Drug Administration to the Massachusetts Department of Public Health, a U.S. state government entity, for Mass MQSA (Mammography Quality Standards Act) inspections. The contract has a firm fixed price pricing type and a potential value of $1,711,136.29. It was awarded on June 1, 2017 with a completion date of June 30, 2022. This contract is not associated with a larger vehicle and does not have a...